A Nationwide Multicenter, Single-arm, Retrospective Study of Delayed Endoscopic DTI-BR After Simple Mastectomy

ConditionBreast Cancer
Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexFemale
Age18-70
SponsorDu Zhenggui

About this trial

This study is a nationwide multicenter, single-arm, retrospective study. The study aims to conduct a detailed analysis of operation-related parameters, aesthetic outcomes (e.g., BREAST-Q scores and Harris scores), and safety (e.g., surgical complication rates) in delayed endoscopic direct-to-implant breast reconstruction via the axillary approach.

Eligibility criteria

Qualifiers

Breast cancer patients who underwent delayed endoscopic direct-to-implant breast reconstruction after simple mastectomy at various centers from July 2024 to August 2025, all delayed endoscopic direct-to-implant breast reconstructions were performed ≥ 6 months after the initial mastectomy.

Disqualifiers

Poor skin elasticity;

Re-evaluation (based on clinical, imaging, and pathological findings) indicates local or regional recurrence or uncontrolled distant metastasis;

Patients who have previously undergone radical mastectomy;

Patients who refused to provide postoperative follow-up information.

Trial design

Treatments tested in this trial

  • delayed endoscopic direct-to-implant breast reconstruction via axillary approach after simple mastectomy

Treatment groups

150 Participants
are divided into 1 treatment group

Sponsors and collaborators

Du Zhenggui

Lead sponsor

West China Hospital

Sponsor institution

Fujian Cancer Hospital

Collaborator

Suzhou Municipal Hospital

Collaborator

The Second People's Hospital of Yibin

Collaborator

Mianyang Central Hospital

Collaborator

West China Hospital

Collaborator

Fourth People's Hospital of Sichuan Province

Collaborator